Open-Source Safety Benchmarks for Medical AI: Why Singapore Hospitals Need Failure Taxonomies

Most medical AI benchmarks measure accuracy: did the model get the right answer? But when we deploy clinical AI in Singapore hospitals, the question that keeps us awake is different: which safety boundary failed when the model got it wrong? A new wave of open-source frameworks is shifting evaluation from correctness to failure mode classification—and that matters for hospitals building governed AI pipelines.

This post is for clinical informatics teams, AI engineers, and hospital CIOs in Singapore evaluating or deploying medical AI systems, especially LLMs and clinical analytics platforms.

Key takeaways

  • Traditional medical AI benchmarks test accuracy; new open-source frameworks classify how models fail by safety gate type (missed escalation, unsafe dosing, evidence fabrication) and clinical severity [2].
  • MedFailBench, released July 2026, provides a clinician-built failure atlas that labels medical AI errors on a 1–5 severity scale and maps them to specific safety boundaries [2].
  • Singapore hospitals deploying clinical LLMs need failure taxonomies to operationalize safety monitoring, triage model errors for clinical review, and meet HSA AI-SaMD and PDPA governance expectations.
  • Open-source longitudinal health agents like HealthClaw separate shared safety rules from private memory, offering a governance-friendly architecture for personal health management [4].
  • Adopting failure-aware evaluation requires clinician-in-the-loop labeling, structured logging, and integration with existing clinical safety workflows—not just swapping benchmark datasets.

Why accuracy benchmarks miss clinical safety failures

When we evaluate a clinical LLM or diagnostic model in Singapore, the standard approach is to measure accuracy, F1 score, or AUROC on a held-out test set. The model either gets the diagnosis right or it doesn't. But in production, a wrong answer can fail in very different ways:

  • Missed urgent escalation: The model reassures a patient with chest pain to rest at home instead of flagging for emergency department triage.
  • Unsafe remote dosing: The model suggests a medication adjustment without accounting for contraindications visible in the EHR.
  • Evidence fabrication: The model cites a non-existent guideline or study to justify a recommendation.
  • Unsafe discharge reassurance: The model tells a post-operative patient that symptoms are normal when they indicate a complication.

These failure modes have different clinical consequences, require different human review workflows, and trigger different governance responses. A model that fabricates evidence needs immediate retraining or removal; a model that occasionally misses low-severity escalations might need better prompt engineering and tighter human-in-the-loop guardrails.

Traditional benchmarks don't distinguish between these. MedFailBench [2], a clinician-built open-source benchmark released in July 2026, does. It labels medical AI errors by severity (1–5) and safety gate type, creating a failure atlas that maps model outputs to specific clinical risks. For Singapore hospitals building clinical AI safety monitoring pipelines, this is the difference between a generic "model performance degraded" alert and a structured "12 unsafe discharge reassurances detected in post-op cohort" flag that clinical teams can act on.

How MedFailBench classifies medical AI failures

MedFailBench [2] is a synthetic benchmark built by clinicians to test safety boundaries, not just knowledge recall. Instead of asking "Does the model know the correct diagnosis?", it asks "When the model fails, which safety gate broke?"

The framework labels errors across several dimensions:

  1. Severity scale (1–5): From minor inconvenience to life-threatening harm.
  2. Safety gate type: Missed urgent escalation, unsafe remote dosing, unsafe discharge reassurance, evidence fabrication, unsafe protocol deviation.
  3. Clinical context: Emergency triage, chronic disease management, post-operative care, medication reconciliation.

This structure lets hospitals:

  • Triage model errors for clinical review: High-severity failures go to clinicians immediately; low-severity errors queue for batch review.
  • Map failures to governance workflows: Evidence fabrication triggers model audit; missed escalations trigger prompt refinement.
  • Track failure patterns over time: Are unsafe discharge reassurances increasing in a specific patient cohort? Is the model fabricating evidence more often after a prompt update?

For Singapore hospitals deploying medical LLMs under HSA's AI-SaMD framework or building PDPA-compliant healthcare AI, failure taxonomies turn abstract "safety monitoring" requirements into concrete operational processes.

Open-source longitudinal health agents: HealthClaw's governance-friendly architecture

Most health AI systems treat each patient interaction in isolation. HealthClaw [4], an open-source agent architecture released in July 2026, takes a different approach: it maintains longitudinal memory across repeated encounters, updating support as a person's routines, preferences, measurements, and risks change.

What makes HealthClaw interesting for Singapore hospital deployments is its architectural separation:

  • Shared safety rules and medical knowledge: Centrally managed, version-controlled, auditable.
  • Private longitudinal memory: Patient-specific facts, reusable procedures, preference history—stored separately, with clear data governance boundaries.

This separation aligns with PDPA requirements for personal health data and makes it easier to audit safety rules without exposing patient-specific information. For hospitals building ambient clinical documentation AI or chronic disease management chatbots, HealthClaw's architecture offers a template for balancing personalization with governance.

The framework is open-source, which means Singapore clinical informatics teams can inspect the safety rule logic, adapt it to local clinical guidelines (e.g., MOH chronic disease management protocols), and integrate it with existing EHR systems. But open-source doesn't mean production-ready: hospitals still need to validate safety rules against local practice, log all agent decisions for audit, and maintain human review workflows for high-risk recommendations.

How to try failure-aware evaluation in your Singapore hospital AI pipeline

If you're deploying clinical LLMs or analytics platforms in Singapore and want to adopt failure-aware evaluation, here's a practical starting point:

Step 1: Define your failure taxonomy

Work with clinicians to map the specific safety boundaries your AI system must respect. For a triage chatbot, this might include:

  • Missed urgent escalation (chest pain, stroke symptoms, severe bleeding)
  • Unsafe remote reassurance (post-operative complications, medication side effects)
  • Evidence fabrication (citing non-existent guidelines)

For a clinical decision support system, add:

  • Unsafe dosing recommendations (contraindications, drug interactions)
  • Protocol deviations (skipping required safety checks)

Step 2: Label a failure test set

Create synthetic or de-identified real cases that test each safety boundary. For each case, label:

  • Ground truth (correct action)
  • Failure mode (which safety gate would break if the model gets it wrong)
  • Severity (1–5 scale)

This is clinician-in-the-loop work. Budget 2–4 hours of clinical time per 50 test cases.

Step 3: Integrate failure classification into your evaluation pipeline

Modify your model evaluation script to classify failures, not just count them. Here's a minimal Python snippet (framework-agnostic):

```python
# Pseudocode: failure-aware evaluation
for case in failure_test_set:
model_output = model.predict(case.input)
if model_output != case.ground_truth:
failure_record = {
"case_id": case.id,
"failure_mode": case.failure_mode, # e.g., "missed_escalation"
"severity": case.severity, # 1-5
"model_output": model_output,
"timestamp": now()
}
log_to_safety_monitoring_db(failure_record)
if case.severity >= 4:
alert_clinical_team(failure_record)
```

Step 4: Build clinical review workflows

Failure classification is only useful if it triggers action. Map each failure mode to a review workflow:

  • Severity 4–5: Immediate clinical review, model output blocked from production.
  • Severity 2–3: Batch review weekly, prompt refinement if pattern detected.
  • Evidence fabrication: Model audit, retraining or removal.

Step 5: Track failure patterns over time

Log all failures to a structured database and build dashboards that show:

  • Failure mode distribution (are missed escalations increasing?)
  • Severity trends (is the model getting safer or riskier?)
  • Cohort-specific patterns (does the model fail more often in elderly patients?)

This is the operational backbone of clinical AI safety monitoring.

Production cautions: evaluation, privacy, logging, and human review

Open-source safety benchmarks and agent frameworks are research tools, not production systems. Before deploying failure-aware evaluation in a Singapore hospital:

  • Validate the failure taxonomy with local clinicians: MedFailBench's safety gates may not map perfectly to your clinical workflows or MOH guidelines.
  • Ensure PDPA compliance for test data: If you're using real patient cases (even de-identified), document data governance, consent, and retention policies.
  • Log all model outputs and failure classifications: HSA AI-SaMD post-market surveillance and PDPA accountability requirements demand audit trails.
  • Maintain human review for high-severity failures: No model is safe enough to bypass clinical judgment for life-threatening decisions.
  • Version-control safety rules and failure taxonomies: When you update the model or prompt, re-run the failure test set and document changes.

For hospitals building LangChain healthcare RAG pipelines or clinical decision support systems, failure-aware evaluation is a governance layer, not a replacement for clinical validation.

Why this matters in Singapore

Singapore's healthcare AI ecosystem is maturing rapidly. MOH's National AI Strategy in Health emphasizes safe, governed deployment. HSA's AI-SaMD framework requires post-market surveillance and risk management. PDPA mandates accountability for automated decisions affecting individuals.

Failure taxonomies turn these abstract requirements into operational processes. Instead of "we monitor model performance," you can say "we classify failures by safety gate type, log severity, and trigger clinical review workflows for high-risk errors." That's the difference between a compliance checkbox and a governed AI system.

For Singapore hospitals deploying medical LLMs, open-source frameworks like MedFailBench and HealthClaw offer practical starting points—but only if you adapt them to local clinical practice, integrate them with existing safety workflows, and maintain clinician-in-the-loop oversight. The frameworks are open; the governance work is still yours.

If you're building clinical AI systems in Singapore and need help designing failure-aware evaluation pipelines, InsytAI's clinical AI services include safety monitoring architecture, clinician-in-the-loop workflows, and HSA/PDPA compliance design.

What to do next

  • Review MedFailBench [2] and map its failure taxonomy to your clinical AI use cases: Which safety gates matter most for your triage chatbot, clinical decision support system, or ambient documentation AI?
  • Convene a clinician working group to label a failure test set: Budget 2–4 hours of clinical time per 50 cases; prioritize high-risk scenarios (emergency triage, medication dosing, post-operative care).
  • Integrate failure classification into your model evaluation pipeline: Log failure mode, severity, and timestamp for every incorrect model output; build dashboards to track patterns over time.
  • Design clinical review workflows for each failure mode: Map severity levels to review cadence (immediate vs. batch); define escalation paths for evidence fabrication and unsafe recommendations.
  • Document your failure taxonomy and review workflows for HSA AI-SaMD and PDPA compliance: Auditors want to see structured safety monitoring, not just accuracy metrics.

Ready to build failure-aware evaluation into your Singapore hospital AI pipeline? Start a project with us or explore our health data infrastructure guide for EHR integration and logging architecture.

FAQ

What's the difference between a failure taxonomy and a traditional confusion matrix?

A confusion matrix tells you how many false positives and false negatives your model produced. A failure taxonomy tells you why each error matters clinically—which safety boundary broke, how severe the harm could be, and what review workflow to trigger. For clinical AI governance, the taxonomy is more actionable.

Can I use MedFailBench to evaluate my hospital's clinical LLM?

MedFailBench [2] is a synthetic benchmark designed to test safety boundaries, not a comprehensive clinical validation dataset. Use it to identify failure modes your model is vulnerable to, then build a hospital-specific test set with local clinical cases, guidelines, and safety rules. MedFailBench is a starting point, not a substitute for clinical validation.

How do I integrate failure classification with existing hospital incident reporting systems?

Map each AI failure mode to an incident category in your hospital's safety reporting system (e.g., medication error, missed diagnosis, communication failure). Log high-severity AI failures (severity 4–5) as incidents; batch-review lower-severity failures weekly. This ensures AI safety monitoring integrates with existing clinical governance workflows, not a parallel system.

Is HealthClaw production-ready for Singapore hospital deployment?

HealthClaw [4] is an open-source research framework, not a production system. Its architecture (separating shared safety rules from private memory) is governance-friendly, but you'll need to validate safety rules against local clinical guidelines, integrate with your EHR, build audit logging, and maintain human review workflows. Treat it as a reference architecture, not a turnkey solution.

Sources

[1] WHO ethics and governance of artificial intelligence for health. World Health Organization, 2021. https://www.who.int/publications/i/item/9789240029200

[2] MedFailBench: A Clinician-Built Open-Source Benchmark for Medical AI Safety Boundary Inspection. arXiv preprint, July 16, 2026. https://arxiv.org/abs/2607.15166v1

[3] Multimodal Semantic-Aware Contrastive Learning For False Negative Mitigation in 3D Medical Imaging. arXiv preprint, July 16, 2026. https://arxiv.org/abs/2607.14995v1

[4] A Self-Evolving Agent for Longitudinal Personal Health Management. arXiv preprint, July 15, 2026. https://arxiv.org/abs/2607.13940v1